Flumazenil-precipitated withdrawal in healthy volunteers following repeated diazepam exposure.
Mintzer
Miriam Z
MZ
Johns Hopkins University School of Medicine, 5510 Nathan Shock Drive, Baltimore, MD 21224, USA. mmintzer@jhmi.edu
Griffiths
Roland R
RR
D000284:Administration, Oral; D000328:Adult; D001794:Blood Pressure / Q000187:drug effects; D003975:Diazepam / Q000009:adverse effects*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D005442:Flumazenil / Q000494:pharmacology*; D018757:GABA Modulators / Q000494:pharmacology*; D006801:Humans; D006993:Hypnotics and Sedatives / Q000009:adverse effects*; D007275:Injections, Intravenous; D008297:Male; D012881:Skin Temperature / Q000187:drug effects; D013375:Substance Withdrawal Syndrome / Q000209:etiology*; D019966:Substance-Related Disorders / Q000534:rehabilitation*
D018757:GABA Modulators; D006993:Hypnotics and Sedatives; D005442:Flumazenil; D003975:Diazepam